risperidone 1 MG/ML Oral Solution

What the CMS Formulary Data Shows for risperidone 1 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, risperidone 1 MG/ML Oral Solution (RxNorm concept RXCUI 199387, generic name risperidone) appears on 328 distinct formulary files spanning 5,052 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.3.

Real-world access to risperidone 1 MG/ML Oral Solution depends on utilization management as much as tier placement: 13.4% of covering formularies require prior authorization. 0% require step therapy. 61.3% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 478,904 Part D beneficiaries filled risperidone 1 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $60,762,873 and an average per-beneficiary annual cost of $126.88. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry risperidone 1 MG/ML Oral Solution today.